跳至主要内容
临床试验/NCT02439255
NCT02439255已完成不适用

Interactive Omics: Black Raspberry Metabolites and the Oral Microbiome in Smokers

Ohio State University Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2015年12月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
1
主要终点
Change of metabolite profile in saliva, urine, and blood using high-performance liquid chromatography-mass spectrometry

研究概览

简要总结

This randomized clinical trial studies the effects of black raspberry compounds (phytochemicals) on the bacteria in the mouth (oral microbiome) of current smokers and non-smokers. The oral microbiome protects the body from pathogenic bacteria. Smoking alters the oral microbiome and may increase the susceptibility to cancer by modulating normal host-bacteria interactions. Black raspberry phytochemicals may protect the oral microbiome of smokers and may lower their risk of developing oral cancer.

详细描述

PRIMARY OBJECTIVES:

I. Determine the effect of black raspberry phytochemicals on community dynamics within oral biofilms.

II. Examine the effect of oral bacterial communities on metabolism of black raspberry phytochemicals in current and never smokers.

III. Evaluate the efficacy of black raspberry phytochemicals and their metabolites in reversing the effect of smoking on oral host-microbial interactions.

OUTLINE: Participants are randomized to 1 of 2 arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects must be periodontally healthy; this is defined as all sites with attachment levels =< 2 mm and probing depths =< 3 mm) and caries-free, as evidenced by a DMF (decayed, missing, filled teeth) Index of less than 5
  • •Subject must be either a current smoker or a never smoker; to define a smoker, we will utilize the Centers for Disease Control definitions; any individual who is currently smoking and has smoked more than 100 cigarettes in their lifetime will be identified as a current smoker; smoking status will be assessed by a questionnaire; since only current and never smokers are included, it is not necessary to measure cotinine levels; the number of cigarettes smoked per day and years of smoking will be used to calculate pack-years, which will be used as a measure of tobacco exposure; a never smoker is defined as a person who never smoked, or smoked less than 100 cigarettes in their lifetime, and who has not had a cigarette in over ten years
  • •Agree to consume a standardized vitamin/mineral supplement and avoid other nutrition, dietary or alternative medications/supplements for the duration of the study
  • •Agree to follow a controlled ellagitannin/low polyphenolic diet and to document consumption of polyphenolic foods each day of the study using our easy to document daily form

排除标准

  • •Have history of oral cancer or carcinoma in-situ
  • •Have had antibiotic therapy or professional cleaning within the previous 3 months
  • •Require antibiotic therapy prior to oral cleaning
  • •Have an active metabolic or digestive illness that impact phytochemical absorption and metabolism, including: diabetes, malabsorptive disorders (Crohn's disease, documented celiac disease, etc.), renal insufficiency (creatinine [Cr] > 1.4), hepatic insufficiency (nonalcoholic steatohepatitis [NASH], cirrhosis, active viral hepatitis), hyper- or hypothyroidism, or short bowel syndrome
  • •Are alcohol consumers (defined as an average consumption of greater than 1 drink/day over one week [wk] [one drink = 1 oz. liquor, 12 oz. beer])
  • •Are taking immunosuppressant medications, bisphosphonates or steroid medications
  • •Currently undergoing treatment for cancer with chemotherapy, hormone therapy, radiation, or biological therapy
  • •Have a known allergy or food intolerance to ingredients in study products (black raspberries or other berries)
  • •Are planning to conceive, or are currently pregnant or lactating
  • •Have had any active oral lesions in the past month or currently have any oral disease or obvious open sores in the oral cavity or surrounding the oral opening
  • •Are taking any medications that have known impact on immune responses (e.g. nonsteroidal anti-inflammatory drugs [NSAIDs] for chronic pain) or are actively being investigated for the prevention of tobacco related cancers will not be acceptable; a single 81 mg aspirin per day will be acceptable

研究组 & 干预措施

Arm I Black raspberry(BRB) nectar

Experimental

Participants receive BRB nectar PO QD for 12 weeks.

干预措施: Laboratory Biomarker Analysis (Other)

Arm I Black raspberry(BRB) nectar

Experimental

Participants receive BRB nectar PO QD for 12 weeks.

干预措施: Phytochemical (Dietary Supplement)

Arm I Black raspberry(BRB) nectar

Experimental

Participants receive BRB nectar PO QD for 12 weeks.

干预措施: Screening Questionnaire Administration (Other)

Arm II (placebo nectar)

Placebo Comparator

Participants receive placebo nectar PO QD for 12 weeks.

干预措施: Laboratory Biomarker Analysis (Other)

Arm II (placebo nectar)

Placebo Comparator

Participants receive placebo nectar PO QD for 12 weeks.

干预措施: Placebo (Other)

Arm II (placebo nectar)

Placebo Comparator

Participants receive placebo nectar PO QD for 12 weeks.

干预措施: Screening Questionnaire Administration (Other)

结局指标

主要结局

Change of metabolite profile in saliva, urine, and blood using high-performance liquid chromatography-mass spectrometry

时间窗: Baseline to up to 12 weeks

The analyses of the metabolite endpoint will use a two-factor (smoking and berry treatment) analysis of variance (ANOVA) model with interaction on the post-treatment minus baseline differences between appropriately transformed data. The number of transcripts as well as the level of each transcript (transformed values) will be used to compute a Bray-Curtis similarity Index between the community profile post-treatment and the baseline profile.

Change in the microbial shift

时间窗: Baseline to 12 weeks

The analyses of the microbial shift data will use a two-factor (smoking and berry treatment) ANOVA model with interaction on the post-treatment minus baseline differences between appropriately transformed data. Phylogenetic distances and community similarity and diversity will be computed from the sequence data. The sensitivity of the phylogenetic analysis to the uncertain knowledge of the phylogenetic relationships will be examined using draws from the posterior distribution of trees in a Mr. Bayes analysis.

次要结局

  • Gene expression levels using next generation sequencing (NGS)(Up to 12 weeks)
  • Food frequency (FF) using the Viocare FF Questionnaire(Week 0)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Purnima Kumar

Principal Investigator

Ohio State University Comprehensive Cancer Center

研究点 (1)

Loading locations...

相似试验